In The News,
In The News,
***Summary***
Last week, the Senate HELP Committee released a bipartisan discussion draft aimed at reducing health care costs. The bill focused on the role that PBMs play in driving up the cost of drugs and included a provision which would ban the practice of “spread pricing,” a tactic PBMs use that allows them to pocket the difference between the price they charge a pharmacy and the wholesale price they pay to the drug manufacturer. This is yet another move by lawmakers and regulators to focus on the role that rebates and PBMs are playing in the drug supply chain.
***
[/el-text]